Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Haemonetics HAE Stock Holding History

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-96,696	Closed	-$10.7M	–	90
2021 Q1	$10.7M	Buy	96,696 +800	+0.8%	+$99K	2.75%	16
2020 Q4	$11.4M	Sell	95,896 -22,608	-19%	-$2.43M	3.14%	13
2020 Q3	$10.3M	Buy	118,504 +29,137	+33%	+$2.55M	3.21%	11
2020 Q2	$8M	Buy	89,367 +8,932	+11%	+$902K	3.08%	13
2020 Q1	$8.02M	Buy	+80,435	New	+$8.72M	4.52%	8

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return

LCP

LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's HAE Position: Q2 2021 in Review

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna sold out of Haemonetics (HAE) in Q2 2021, closing a stake of 96,696 shares — an estimated $10.7M sold.

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in HAE in Q1 2020 and held it in 5 quarters. The position peaked at $11.4M in Q4 2020. 258 funds tracked by Wall St. Rank hold HAE as of Q2 2021.

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna reported no remaining Haemonetics position as of Q2 2021 after selling out during the quarter.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna sold 96,696 Haemonetics shares in Q2 2021, an estimated $10.7M.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in Haemonetics in Q1 2020 and held it in 5 quarters.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's Haemonetics position peaked at $11.4M in Q4 2020.
258 funds tracked by Wall St. Rank held Haemonetics as of Q2 2021.

Based on Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's 13F filing for Q2 2021, filed 2 Sep 2025.